Researchers at the University of Colorado Anschutz Medical Campus have investigated how antiviral proteins called interferons interact with SARS-CoV-2, the cause of COVID-19. The study, published in Proceedings of the National ...
Jul 25, 2022
0
138
Some cytokines can enhance the production of aberrantly O-glycosylated IgA1, the main autoantigen in IgA nephropathy. The mechanism behind this observation is described in the Journal of Interferon & Cytokine Research (JICR).
Jul 19, 2022
0
5
Researchers from the National Cancer Institute, part of the National Institutes of Health, and their collaborators have discovered that people of European and African ancestries who were hospitalized for COVID-19 are more ...
Jul 15, 2022
0
6
Immunologists from Trinity, who have worked on coronaviruses for the past decade, have just unraveled new secrets behind the viruses' battle plans—providing new insights into how these deadly viruses sometimes win the war ...
Apr 12, 2022
0
23
As Americans cross their fingers, hoping the pandemic stays behind them, scientists across the country remain focused on the novel coronavirus, intent on combating its next move.
Mar 28, 2022
0
68
Obesity is among the biggest health challenges of the 21st century, according to the World Health Organization (WHO). Almost 60% of Germans are considered overweight, while 25% are obese. Moreover, being overweight often ...
Mar 17, 2022
0
45
For all the misery that the pandemic has wrought, it has also opened up a vast storehouse of knowledge about medical issues beyond COVID-19. While it's still too early to draw conclusions, evidence is emerging of links between ...
Feb 16, 2022
0
5
As messenger substances, interferons stimulate various responses of immune cells and play a key role in activating the immune system. They are proven active agents against various diseases, especially type I interferon alpha ...
Feb 14, 2022
0
36
What is going on at the single-cell level in the first days of SARS-CoV-2 infection in the lungs?
Feb 8, 2022
0
67
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
Oct 20, 2021
0
6
